Company Products Knowledge Center Investors Contact Toggle search form Investor Home Governance Press Releases (current) Financials Stock Information Investor Contact Press Releases These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email link below. Get News Alerts by Email Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Nov 17 2021 BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™ BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced... Nov 15 2021 BioLife Solutions Named to Inc. Magazine Inaugural List of Best-Led Companies Number 200 out of 250; more than 10,000 companies profiled BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies and the... Nov 11 2021 BioLife Solutions Announces Third Quarter 2021 Financial Results Total revenue up 200% over Q3 2020; organic revenue up 37% over Q3 2020 driven by 49% growth in media revenue BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the... Nov 04 2021 BioLife Solutions Announces Executive Management Changes BioLife Solutions, Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets,... Nov 04 2021 BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021 BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced... Show 5 per page «123456789…69» Search for: Search Investor Alerts Company About Our Company Leadership Careers Press Biopreservation Media Freezers Cryogenic Storage Services Cold Chain Management Thawing CBS Product Catalog Knowledge Center Ask the Scientists Evidence Library Investor Relations Contact 3303 Monte Villa Parkway, Suite 310, Bothell, WA 98021 Telephone: +1.866.424.6543 or 425.402.1400 FAX: +1.425.402.1433 info@biolifesolutions.com twitter linkedin facebook Feedback Site Map Terms & Conditions Privacy